BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38443362)

  • 1. CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA.
    Tang C; Zhuang H; Wang W; Wang Q; Ma X; Wang B; Zhang Z; Jiang J; Xie Z; Tan W; Yang L; Liu S; Hua Y; Xiao Y; Ding B; Chen Y; Shang C
    Cell Death Dis; 2024 Mar; 15(3):191. PubMed ID: 38443362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.
    Liu H; Lan T; Li H; Xu L; Chen X; Liao H; Chen X; Du J; Cai Y; Wang J; Li X; Huang J; Yuan K; Zeng Y
    Theranostics; 2021; 11(3):1396-1411. PubMed ID: 33391541
    [No Abstract]   [Full Text] [Related]  

  • 3. circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-κB pathway.
    Wu F; Sun G; Zheng W; Tang W; Cheng Y; Wu L; Li X; Tao J; Ma S; Cao H
    J Clin Lab Anal; 2021 Dec; 35(12):e24003. PubMed ID: 34676904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 6. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR.
    Liu B; Yang G; Wang X; Liu J; Lu Z; Wang Q; Xu B; Liu Z; Li J
    J Cell Physiol; 2020 Oct; 235(10):6929-6941. PubMed ID: 32003018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis.
    Li Z; Liu Y; Yan J; Zeng Q; Hu Y; Wang H; Li H; Li J; Yu Z
    Aging (Albany NY); 2020 Feb; 12(3):2485-2497. PubMed ID: 32048611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
    Cao S; Wang G; Wang J; Li C; Zhang L
    Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_Circ_101141 as a Competing Endogenous RNA Facilitates Tumorigenesis of Hepatocellular Carcinoma by Regulating miR-1297/ROCK1 Pathway.
    Zhang T; Zhang L; Han D; Tursun K; Lu X
    Cell Transplant; 2020; 29():963689720948016. PubMed ID: 32787581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
    Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
    Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
    Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
    Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
    Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C
    Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA-124 in regulation of Hepatocellular carcinoma through BIRC3 and the NF-κB pathway.
    Cao J; Qiu J; Wang X; Lu Z; Wang D; Feng H; Li X; Liu Q; Pan H; Han X; Wei J; Liu S; Wang L
    J Cancer; 2018; 9(17):3006-3015. PubMed ID: 30210622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.